Inflammation-driven diseases

High levels of inflammation are often seen in people with obesity and are linked to conditions like heart disease, diabetes, digestive disorders, and even memory-related illnesses.

Study purpose

This new medication may help lower overall inflammation levels, improve how the body responds to insulin, and potentially reduce the risk or progression of several chronic diseases.

Requirements

​​

• Aged >18 years

• Overall healthy or with controlled chronic conditions

• This is for patients with obesity

​

Major Disqualifications​

​

• Currently pregnant or breastfeeding

• Substance abuse

• Uncontrolled chronic conditions